Insulin port device co gets $15m boost:
This article was originally published in Clinica
Austin, Texas-based Patton Medical Devices is ramping up US sales of its I-Port injection port, after receiving $15m from institutional investors. This brings the total investment in the company to $27m. The company's device incorporates a tube that is inserted into the skin, providing diabetics with a readily available channel for injecting their insulin and reducing the need for repeated piercing of the skin. The port can accommodate 75 injection and be worn for up to 72 hours.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.